Company Overview of PhaseBio Pharmaceuticals, Inc.
PhaseBio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing drugs for endocrine and metabolic disorders, and cardiovascular disease. Its products include PB1023 for the treatment of hyperglycemia associated with type 2 diabetes, as well as with a potential for future use in the treatment of obesity; Insumera, a basal insulin ELP-fusion; and Vasomera, a vasoactive intestinal peptide agonist for acute and chronic heart failure and pulmonary arterial hypertension. PhaseBio Pharmaceuticals, Inc. was formerly known as Phase Bioscience, Inc. and it changed its name in November 2008. The company was founded in 2002 and is based in Malvern, Pennsylvania.
One Great Valley Parkway
Malvern, PA 19355
Founded in 2002
Key Executives for PhaseBio Pharmaceuticals, Inc.
PhaseBio Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Audeo Oncology, Inc.||United States|
|D-finitive Technologies, Inc.||United States|
|ICx Biosystems||United States|
|Recombinetics, Inc.||United States|
|Nova BioGenetics Inc.||United States|
Recent Private Companies Transactions
February 26, 2015
To contact PhaseBio Pharmaceuticals, Inc., please visit www.phasebio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.